Trichuris suis Ova in Inflammatory Bowel Disease

Digestive Diseases

Volumn 31, Issue 3-4, 2013, Pages 391-395

  Schölmerich, Jürgen ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Crohn's disease; Helminths; IBD treatment; Trichuris suis; Ulcerative colitis

Indexed keywords

INTERLEUKIN 10;

ALLERGIC ENCEPHALOMYELITIS; ANCYLOSTOMA CEYLANICUM; CHILDHOOD DISEASE; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; CROHN DISEASE; DISEASE MODEL; EPIDEMIOLOGICAL DATA; EXPERIMENTAL MODEL; HELIGMOSOMOIDES POLYGYRUS; HUMAN; HYMENOLEPIS DIMINUTA; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MUCOSAL IMMUNITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHISTOSOMA MANSONI; THERAPY EFFECT; THERAPY WITH HELMINTHS; TRICHURIS MURIS; TRICHURIS SUIS; ULCERATIVE COLITIS; BACTERIAL FLORA; CONTROLLED CLINICAL TRIAL (TOPIC); INFLAMMATORY BOWEL DISEASE; MULTICENTER STUDY (TOPIC); NEMATODE LIFE CYCLE STAGE; ANIMAL; INFLAMMATORY BOWEL DISEASES; PARASITOLOGY; PHYSIOLOGY; TRICHURIS;

ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; OVUM; TRICHURIS;

EID: 84888265669     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000354708     Document Type: Conference Paper

References (32)

1. Danese S: New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 2012; 61: 918-932.
2. Casanova J-L, Abel L: Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med 2009; 206: 1839-1843.
3. Marks D: Defective innate immunity in inflammatory bowel disease: a Crohn's disease exclusivity Curr Opin Gastroenterol 2011; 27: 328-334.
4. Rook G: Hygiene and other early childhood influences on the subsequent function of the immune system. Dig Dis 2011; 29: 144-153.
5. Smith AM, Rahman FZ, Hayee BH, Graham SJ, Marks DJB, Sewell GW, Palmer CD, Wilde J, Foxwell BMJ, Gloger IS: Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009; 206: 1883-1897.
6. Gutierrez A, Holler E, Zapater P, Sempere L, Jover R, Perez-Mateo M, Schoelmerich J, Such J, Wiest R, Frances R: Antimicrobial peptide response to blood translocation of bacterial DNA in Crohn's disease is affected by NOD2/CARD15 Genotype. Inflamm Bowel Dis 2011; 17: 1641-1650.
7. Weinstock JV: The worm returns. Nature 2012; 491: 183-185.
8. Elliot DE, Weinstock J: Where are we on worms Curr Opin Gastroenterol 2012; 28: 551-556.
9. Reddy A, Fried B: An update on the use of helminths to treat Crohn's and other autoimmunune diseases. Parasitol Res 2009; 104: 217-221.
10. Erb KJ: Can helminths or helminths-derived products be used in humans to prevent or treat allergic diseases Trends Immunol 2009; 30: 75-82.
11. Elliot DE, Weinstock JV: Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann NY Acad Sci 2012; 1247: 83-96.
12. Walk ST, Blum AM, Ewing SAS, Weinstock JV, Young VB: Alteration of the murine gut microbiota during infection with the parasitic helminth, Heligmosomoides polygyrus . Inflamm Bowel Dis 2010; 16: 1841-1849.
13. Hang L, Setiwan T, Blum A, Urban J, Stoyanoff K, Arihiro S, Reinecker H-C, Weinstock JV: Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J Immunol 2010; 185: 3184-3189.
14. Elliot DE, Setiwan T, Metwali A, Blum A, Urban JF, Weinstock JV: Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004; 34: 2690-2698.
15. Hafner S, Timmer A, Herfarth H, Rogler G, Scholmerich J, Schaffler A, Ehrenstein B, Jilg W, Ott C, Strauch UG, Obermeier F: The role of domestic hygiene in inflammatory bowel disease: hepatitis A and worm infestations. Eur J Gastroenterol Hepatol 2008; 20: 561-566.
16. Fumagalli M, Pozzoli U, Cagliani R, Comi GP, Riva S, Clerici M, Bresolin N, Sironi M: Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med 2009; 206: 1395-1408.
17. Kabeerdoss J, Pugazhendhi S, Subramanian V, Binder HJ, Ramakrishna BS: Exposure to hookworms in patients with Crohn's disease: a case-control study. Aliment Pharmacol Ther 2011; 34: 923-930.
18. Bager P, Vinkel Hansen A, Wohlfahrt J, Melbye M: Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. Gastroenterology 2012; 142: 55-62.
19. Aoyama H, Hirata T, Sakugawa H, Watanabe T, Miyagi S, Maeshiro T, Chinen T, Kawane M, Zaha O, Nakayoshi T, Kinjo F, Fujito J: An inverse relationship between autoimmune liver diseases and Strongyloides stercoralis infection. Am J Trop Med Hyg 2007; 76: 972-976.
20. Correale J, Farez M: Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007; 61: 97-108.
21. Hunter MM, Wang A, Hirota CL, McKay DM: Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol 2005; 174: 7368-7375.
22. Moreels TG, Nieuwendijk RJ, De Man JG, De Winter BY, Herman AG, Van Marck EA, Pelckman PA: Concurrent infection with Schistosoma mansoni attenuates inflammation-induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid-induced colitis in rats. Gut 2004; 53: 99-107.
23. Lopes Cancado GG, Araujo Fiuza J, Nogueira de Paiva NC, de Carvalho Dhom Lemos L, Delaqua Ricci N, Gazzinenelli-Guimaraes PH, Gandra Martins V, Bartolomeu DC, Negrao-Correa DA, Martins Carneiro C, Fujiwara RT: Hookworm products ameliorate dextran sodium sulfate-induced colitis in BALB/c mice. Inflamm Bowel Dis 2011; 17: 2275-2286.
24. Schnoeller C, Rausch S, Pillai S, Avagyan A, Wittig BM, Loddenkemper C, Hamann A, Hamelmann E, Lucius R, Hartmann S: A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 2008; 180: 4265-4272.
25. Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, Cook TD, Field AS, Boland J, Fabry Z: Probiotic helminths administration in relapsing-remitting multiple sclerosis: a phase I study. Mult Scler 2001; 17: 743-754.
26. Bager P, Arnved J, Ronborg S: Trichuris suis ova therapy for allergic rhinitis: a randomized double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol 2010; 125: 123-130.
27. Croese J, O'Neil J, Masson J, Cooke S, Melrose W, Pritchard D, Speare R: A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 2006; 55: 136-137.
28. Broadhurst MJ, Leung JM, Kashyap V, Mc-Cune JM, Mahadevan U, McKerrow JH, Loke P: IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med 2010; 60: 60-88.
29. Summers RW, Elliot DE, Qadir K: Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003; 98: 2034-2041.
30. Summers RW, Elliot DE, Urban JF: Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128: 825-832.
31. Summers RW, Elliot DE, Urban JF: Trichuris suis therapy in Crohn's disease. Gut 2005; 54: 87-90.
32. Sandborn WJ, Elliott DE, Weinstock J, Summers RW, Landry-Wheeler A, Silver N, Harnett MD, Hanauer SB: Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease. Aliment Pharmacol Ther 2013; 38: 255-263.